<DOC>
	<DOCNO>NCT00630721</DOCNO>
	<brief_summary>Determine in-vivo mechanism action INF-B-1b 's mechanisms action completely understood . We propose high dose exogenous recombinant IFN-B-1b induces tolerizing effect DC-dependent T-cell differentiation patient MS induce expression SOCS3 DCs .</brief_summary>
	<brief_title>Characterization Interferon Beta -1b-Induced Tolerizing Effect Dendritic Cells</brief_title>
	<detailed_description />
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<criteria>Confirmed diagnosis MS Age 1860 year , inclusive Expanded disability status 06.5 Give write informed consent prior test protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>